Atezolizumab in "Real World" Patients: Do Phase 3b Trials Help Bridge the Gap Between Efficacy and Effectiveness?

Patel, Vaibhav G; Galsky, Matthew D

Patel, Vaibhav G; Galsky, Matthew D.

Afiliação

Patel VG; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: vaibhav.patel@mountsinai.org.
Galsky MD; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Eur Urol ; 76(1): 82-83, 2019 07.

Article em En | MEDLINE | ID: mdl-31006493

Assuntos

Carcinoma; Neoplasias Pulmonares; Sistema Urinário; Anticorpos Monoclonais; Anticorpos Monoclonais Humanizados; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema Urinário / Carcinoma / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Eur Urol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google